Innovations Inc Pyxis serves as Executive at INTERLEUKIN GENETICS INC, where they oversee executive responsibilities. Since joining the company, Innovations Inc Pyxis has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 11, 2008 involved exercising options for 943,032 shares valued at $603.5K.
Innovations Inc Pyxis currently holds 6,884,057 shares of INTERLEUKIN GENETICS INC (ILI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Innovations Inc Pyxis has been a net neutral trader of ILI stock. They have purchased $0 and sold $0 worth of shares.
Innovations Inc Pyxis's most recent insider trade was on Jun 11, 2008, when they sold 943,032 shares at $0.64 per share.
Get notified when new Form 4 filings are submitted
| $0.64 |
| Discretionary |